Newsfeeds - Spark Newswire

1 minute read

Earnings

Recap: AtriCure Q4 Earnings

Today, 4:30 AM

AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by 3.45%, reporting an EPS of $-0.3 versus an estimate of $-0.29.

ATRC

1 minute read

AtriCure Q4 EPS $(0.30) Misses $(0.29) Estimate, Sales $73.22M Beat $72.65M Estimate

By Benzinga Newsdesk

Today, 4:30 AM

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 66.67 percent decrease over losses of $(0.18) per share from the

ATRC

3 minute read

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More

By Shanthi Rexaline

Today, 4:30 AM

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.

ADPT

1 minute read

Needham Maintains Buy on AtriCure, Raises Price Target to $92

By Benzinga Newsdesk

Today, 4:30 AM

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $90 to $92.

ATRC

1 minute read

SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $110

By Benzinga Newsdesk

Today, 4:30 AM

SVB Leerink analyst Danielle Antalffy maintains AtriCure (NASDAQ:ATRC) with a Outperform and raises the price target from $100 to $110.

ATRC

1 minute read

AtriCure Q3 EPS $2.11 Up From $(0.11) YoY, Sales $70.50M Beat $68.68M Estimate

By Benzinga Newsdesk

Today, 4:30 AM

AtriCure (NASDAQ:ATRC) reported quarterly earnings of $2.11 per share. This is a 2018.18 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $70.50

ATRC

25 minute read

Earnings Scheduled For November 3, 2021

By Benzinga Insights

Today, 4:30 AM

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.

AAWW

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 4:30 AM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

1 minute read

Earnings

Return on Capital Employed Insights for AtriCure

By Benzinga Insights

Today, 4:30 AM

After pulling data from Benzinga Pro it seems like during Q2, AtriCure's (NASDAQ:ATRC) reported sales totaled $71.38 million. Despite a 5.09% in earnings, the company posted a loss of $15.08 million.

ATRC